Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cytokinetics
(NQ:
CYTK
)
62.10
-1.92 (-3.00%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,343,714
Open
63.63
Bid (Size)
61.00 (1)
Ask (Size)
62.10 (1)
Prev. Close
64.02
Today's Range
61.25 - 64.61
52wk Range
25.98 - 110.25
Shares Outstanding
95,640,600
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
CYTK Stock Earnings: Cytokinetics Misses EPS, Misses Revenue for Q1 2024
May 08, 2024
CYTK stock results show that Cytokinetics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare
May 07, 2024
Investors concerned about broader market undulations may want to consider the resilience narrative of these biotech stocks to buy.
Via
InvestorPlace
Performance
YTD
-26.18%
-26.18%
1 Month
-16.49%
-16.49%
3 Month
-19.29%
-19.29%
6 Month
+91.08%
+91.08%
1 Year
+64.16%
+64.16%
More News
Read More
(CYTK) - Analyzing Cytokinetics's Short Interest
May 01, 2024
Via
Benzinga
3 Biotech Stocks to Buy on the Dip: April 2024
April 26, 2024
Via
InvestorPlace
$100 Invested In Cytokinetics 5 Years Ago Would Be Worth This Much Today
April 03, 2024
Via
Benzinga
2 Incredible Growth Stocks to Buy Right Now
March 20, 2024
Via
The Motley Fool
Here's How Much $100 Invested In Cytokinetics 10 Years Ago Would Be Worth Today
March 15, 2024
Via
Benzinga
Unpacking the Latest Options Trading Trends in Cytokinetics
February 28, 2024
Via
Benzinga
Here's How Much $1000 Invested In Cytokinetics 10 Years Ago Would Be Worth Today
February 27, 2024
Via
Benzinga
7 Biotech Stocks Ready to Ride the Sector’s Resurgence
March 18, 2024
Via
InvestorPlace
Masters In Trading - Saturday, March 16
March 16, 2024
Via
Talk Markets
7 Biotech Stocks to Buy as Sector Rotation Ramps Up
March 13, 2024
Via
InvestorPlace
Super Micro, Deckers To Join S&P 500 Index
March 01, 2024
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Earnings Scheduled For February 27, 2024
February 27, 2024
Via
Benzinga
Here's How Much $1000 Invested In Cytokinetics 5 Years Ago Would Be Worth Today
February 09, 2024
Via
Benzinga
Here's How Much $100 Invested In Cytokinetics 5 Years Ago Would Be Worth Today
February 02, 2024
Via
Benzinga
Overbought, Overextended - What's The Buzz In S&P 500 Now?
February 14, 2024
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
3 Biotech Stocks to Buy for the Next Bull Run: February 2024
February 08, 2024
Via
InvestorPlace
How Cytokinetics Overcame Two Setbacks And Doubled Its Stock Price Over A Month
February 08, 2024
Via
Investor's Business Daily
Banco Santander, Lloyds Banking And Other Big Stocks Moving Lower In Monday's Pre-Market Session
February 05, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
3 Healthcare Stocks at 52-Week Lows: Buy or Bye?
January 26, 2024
Via
InvestorPlace
Biotech Playbook: Small Caps Show Momentum Peaking During
January 15, 2024
Via
Talk Markets
10 Health Care Stocks With Whale Alerts In Today's Session
January 15, 2024
Via
Benzinga
Cytokinetics' Heart Drug Is A Multi-Billion Dollar Opportunity By 2032 Despite Novartis Setback: Analyst
January 12, 2024
Via
Benzinga
Novartis Retreats From Cytokinetics Deal, Dashing Hopes For Multi-Billion Dollar Acquisition
January 11, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.